The Tyrosine Kinase Inhibitor Dasatinib impedes adaptive cell surveillance in peripheral lymph nodes

被引：0
|
作者：
Carvoeiro, Daniela Claudino [1 ]
Marcos-Jimenez, Ana [2 ]
Munoz-Calleja, Cecilia [2 ,3 ]
Stein, Jens Volker [1 ]
机构：
[1] Univ Fribourg, Dept Oncol Microbiol & Immunol, Fribourg, Switzerland
[2] La Princesa Hosp IIS IP, Biomed Res Inst, Dept Immunol, Madrid, Spain
[3] Inst Salud Carlos III, CIBER Infect Dis CIBERINFECC, Madrid, Spain
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1435 - P2.
引用
收藏
页码：1099 / 1099
页数：1
相关论文
共 50 条
  • [41] He tyrosine kinase inhibitor dasatinib suppresses IGE-dependent activation and histamine release in basophils
    Kneidinger, M.
    Gleixner, K. V.
    Boehm, A.
    Vales, A.
    Sonneck, K.
    Florian, S.
    Weghofer, M.
    Lupinek, C.
    Vrtala, S.
    Valenta, R.
    Superti-Furga, G.
    Lee, F. Y.
    Valent, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 112 - 112
  • [42] Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib
    Haeselbarth, Lukas
    Karow, Axel
    Mentz, Kristin
    Boettcher, Martin
    Roche-Lancaster, Oisin
    Krumbholz, Manuela
    Jitschin, Regina
    Mougiakakos, Dimitrios
    Metzler, Markus
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (06) : 1661 - 1672
  • [43] Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib
    Lukas Häselbarth
    Axel Karow
    Kristin Mentz
    Martin Böttcher
    Oisin Roche-Lancaster
    Manuela Krumbholz
    Regina Jitschin
    Dimitrios Mougiakakos
    Markus Metzler
    Cancer Immunology, Immunotherapy, 2023, 72 : 1661 - 1672
  • [44] The Tyrosine Kinase Inhibitor Dasatinib Induces a Marked Adipogenic Differentiation of Human Multipotent Mesenchymal Stromal Cells
    Borriello, Adriana
    Caldarelli, Ilaria
    Basile, Maria Assunta
    Bencivenga, Debora
    Tramontano, Annunziata
    Perrotta, Silverio
    Della Ragione, Fulvio
    Oliva, Adriana
    PLOS ONE, 2011, 6 (12):
  • [45] Lymph node fibrosis impedes peripheral CD4+ T-cell count
    Roberts, JP
    SCIENTIST, 2003, 17 (02): : 24 - 24
  • [46] Mantle Cell Hyperplasia of Peripheral Lymph Nodes as Initial Manifestation of Sickle Cell Disease
    Monabbati, Ahmad
    Noori, Sadat
    Safaei, Akbar
    Ramzi, Mani
    Eghbali, Seyedsajjad
    Adib, Ali
    CASE REPORTS IN HEMATOLOGY, 2016, 2016
  • [47] Crizotinib - a tyrosine kinase inhibitor that stimulates immunogenic cell death
    Liu, Peng
    Zhao, Liwei
    Kepp, Oliver
    Kroemer, Guido
    ONCOIMMUNOLOGY, 2019, 8 (07):
  • [48] TYROSINE KINASE INHIBITOR EFFECTS ON CYTOSKELETAL ORGANIZATION AND CELL MOTILITY
    ROMER, LH
    TURNER, CE
    BURRIDGE, K
    MOLECULAR BIOLOGY OF THE CELL, 1992, 3 : A232 - A232
  • [49] Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging
    Rodriguez-Agustin, Andrea
    Casanova, Victor
    Grau-Exposito, Judith
    Sanchez-Palomino, Sonsoles
    Alcami, Jose
    Climent, Nuria
    PHARMACEUTICS, 2023, 15 (03)
  • [50] Hair Depigmentation During Chemotherapy With Dasatinib, a Dual Bcr-Abl/Src Family Tyrosine Kinase Inhibitor
    Sun, Angel
    Akin, Russel S.
    Cobos, Everado
    Smith, Jennifer
    JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (04) : 395 - 398
12345